NICE on dementia: Omitting donepezil is hardly a hardship
- PMID: 17991951
- PMCID: PMC2072019
- DOI: 10.1136/bmj.39388.433137.1F
NICE on dementia: Omitting donepezil is hardly a hardship
Conflict of interest statement
Competing interests: None declared.
References
-
- Gulland A. NICE guidelines create ethical dilemmas in care of elderly people, says report. BMJ 2007;335:791 (20 October.) doi:10.1136/bmj.39371.570509.DB - DOI - PubMed
-
- Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, et al, AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 2004;363:2105-15. - PubMed
-
- Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, Bullock R, et al; CALM-AD Trial Group. Donepezil for the treatment of agitation in Alzheimer's disease. N Engl J Med 2007;357:1382-92. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical